- Home
- LOBO vs KLTO Comparison
LOBO vs KLTO Comparison
Compare LOBO & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOBO
- KLTO
- Stock Information
- Founded
- LOBO 2014
- KLTO 2019
- Country
- LOBO China
- KLTO United States
- Employees
- LOBO N/A
- KLTO N/A
- Industry
- LOBO
- KLTO
- Sector
- LOBO
- KLTO
- Exchange
- LOBO NYSE
- KLTO NYSE
- Market Cap
- LOBO 6.4M
- KLTO 5.9M
- IPO Year
- LOBO 2024
- KLTO N/A
- Fundamental
- Price
- LOBO $0.55
- KLTO $0.71
- Analyst Decision
- LOBO
- KLTO
- Analyst Count
- LOBO 0
- KLTO 0
- Target Price
- LOBO N/A
- KLTO N/A
- AVG Volume (30 Days)
- LOBO 172.8K
- KLTO 84.5M
- Earning Date
- LOBO 04-29-2025
- KLTO 08-15-2025
- Dividend Yield
- LOBO N/A
- KLTO N/A
- EPS Growth
- LOBO N/A
- KLTO N/A
- EPS
- LOBO N/A
- KLTO N/A
- Revenue
- LOBO $21,188,606.00
- KLTO N/A
- Revenue This Year
- LOBO $77.34
- KLTO N/A
- Revenue Next Year
- LOBO N/A
- KLTO N/A
- P/E Ratio
- LOBO N/A
- KLTO N/A
- Revenue Growth
- LOBO 36.92
- KLTO N/A
- 52 Week Low
- LOBO $0.46
- KLTO $0.11
- 52 Week High
- LOBO $3.52
- KLTO $3.91
- Technical
- Relative Strength Index (RSI)
- LOBO N/A
- KLTO N/A
- Support Level
- LOBO N/A
- KLTO N/A
- Resistance Level
- LOBO N/A
- KLTO N/A
- Average True Range (ATR)
- LOBO 0.00
- KLTO 0.00
- MACD
- LOBO 0.00
- KLTO 0.00
- Stochastic Oscillator
- LOBO 0.00
- KLTO 0.00
About LOBO LOBO EV TECHNOLOGIES LTD
Lobo EV Technologies Ltd is an electric vehicle manufacturer and seller company. It designs, develops, manufactures, and sells e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons, also provides automobile information and entertainment software development and design services to customers. The company operates in two operating segments: the Electric vehicles and accessories sales segment, which generates key revenue, and the software royalties and development and design services segment. It generates all of its revenue within the People's Republic of China.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.